E-viri
Recenzirano
-
New oncologic emergencies: What is there to know about inmunotherapy and its potential side effects?Barquín-García, Arantzazu; Molina-Cerrillo, Javier; Garrido, Pilar; Garcia-Palos, Daniel; Carrato, Alfredo; Alonso-Gordoa, Teresa
European journal of internal medicine, August 2019, 2019-Aug, 2019-08-00, 20190801, Letnik: 66Journal Article
Over the last decade anticancer treatment has experienced encouraging changes. One of the latest developments is immunotherapy, which is increasingly becoming a mainstay for the treatment of these malignancies. Unlike conventional chemotherapy, immunotherapy enhances anti-tumor immune response by blocking inhibitory immune checkpoints, and allowing our own immune system to fight against the tumor cells, arising as a new and innovative mechanism of action. Therefore, although well tolerated, these drugs have a unique side effect profile and are known to cause immune-related adverse events (irAEs). Adverse effects of immunotherapy are most commonly observed in the skin, gastrointestinal tract, liver, lung and endocrine systems. Less common toxicities may include neurological, haematological, cardiac, ocular or rheumatologic involvement. As far as we know, cancer patients are frequently seen in the Emergency Department due to treatment related toxicities, thus there is an increasing necessity to learn about this particular side effect profile given that they entail a different and unique management than that of classic chemotherapy drugs. •Immunotherapy blocks inhibitory immune checkpoints allowing our immune system to fight against tumor cells.•Most frequent irAEs affect skin, gastrointestinal, liver, lung and endocrine systems.•Timely intervention with corticosteroids is crucial to limit the severity of irAEs.•Corticosteroids are generally indicated together with dose skipping or discontinuation for persistent grade ≥2 irAEs.•Severe irAEs, grade 3-4, may require additional immunosuppressive agents and a multidisciplinary approach.
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.